Delayed Start to Ovarian Stimulation
Status: | Terminated |
---|---|
Conditions: | Women's Studies, Infertility |
Therapuetic Areas: | Reproductive |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | May 2012 |
End Date: | September 2014 |
Delayed Start to Ovarian Stimulation Improves Oocyte Maturation and Quality: A Randomized Trial
In couples with infertility secondary to Diminished Ovarian Reserve, the investigators
hypothesize that a delayed start (7 day) to ovarian stimulation with an GnRH antagonist
(Ganirelix) will improve oocyte maturation and quality, and improve pregnancy outcomes.
hypothesize that a delayed start (7 day) to ovarian stimulation with an GnRH antagonist
(Ganirelix) will improve oocyte maturation and quality, and improve pregnancy outcomes.
Over the past two decades, the success rate of assisted reproductive technology (ART) has
dramatically increased. This increase is attributed to improvements in embryo culture,
laboratory conditions, and optimization of ovarian stimulation protocols. Over the past
years, there has been more interest in altering the ovarian stimulation protocol to improve
outcomes. For example, recently our group found that a modification of ovulation trigger
toward a more physiologic process improves oocyte quality and pregnancy outcomes. Others
have suggested minimal stimulation improves in vitro fertilization (IVF) outcomes. The
investigators propose to further investigate modifying the ovarian stimulation for women who
have "decreased" ovarian reserve. The investigators propose that a delayed start to ovarian
stimulation will improve oocyte maturation and quality and pregnancy outcomes. No published
studies to date have evaluated if a delayed start to ovarian stimulation improves pregnancy
outcomes. However, the investigators hypothesize that the use an antagonist for a delayed
start of stimulation will work by one of two mechanisms:
I. The partial suppression of FSH will allow for further recruitment of early antral
follicles.
II. The partial suppression of FSH will allow for further FSH responsiveness in existing
follicles to synchronize the primary cohort, thereby increasing the total number of
follicles.
dramatically increased. This increase is attributed to improvements in embryo culture,
laboratory conditions, and optimization of ovarian stimulation protocols. Over the past
years, there has been more interest in altering the ovarian stimulation protocol to improve
outcomes. For example, recently our group found that a modification of ovulation trigger
toward a more physiologic process improves oocyte quality and pregnancy outcomes. Others
have suggested minimal stimulation improves in vitro fertilization (IVF) outcomes. The
investigators propose to further investigate modifying the ovarian stimulation for women who
have "decreased" ovarian reserve. The investigators propose that a delayed start to ovarian
stimulation will improve oocyte maturation and quality and pregnancy outcomes. No published
studies to date have evaluated if a delayed start to ovarian stimulation improves pregnancy
outcomes. However, the investigators hypothesize that the use an antagonist for a delayed
start of stimulation will work by one of two mechanisms:
I. The partial suppression of FSH will allow for further recruitment of early antral
follicles.
II. The partial suppression of FSH will allow for further FSH responsiveness in existing
follicles to synchronize the primary cohort, thereby increasing the total number of
follicles.
Inclusion Criteria:
- Antral Follicle Count (AFC) less than or equal to 4 as measured by transvaginal
ultrasound (TVUS), or
- Cancellation of a prior IVF cycle due to poor ovarian response.
- Patients will receive an antagonist stimulation protocol for IVF, or IVF with
Intracytoplasmic Sperm Injection (ICSI).
Exclusion Criteria:
- Severe male factor infertility requiring surgical intervention to obtain sperm
- Major uterine abnormality,
- Preimplantation genetic diagnostic (PGD) testing,
- Planned cycles without embryo transfer (for example, freeze-all, donor, or surrogate
cycles).
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials